My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 338

    1.

    Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes.

    Boden G, Chen X, Capulong E, Mozzoli M.

    Diabetes. 2001 Apr;50(4):810-6.PMID: 11289046 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.

    Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, Landau BR, Nowotny P, Waldhäusl W, Shulman GI.

    Diabetes. 2000 May;49(5):701-7.PMID: 10905476 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.

    Toft I, Jenssen T.

    Scand J Clin Lab Invest. 2005;65(4):307-20.PMID: 16076686 [PubMed - indexed for MEDLINE]Related articles

    4.

    FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.

    Boden G, Cheung P, Stein TP, Kresge K, Mozzoli M.

    Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E12-9.PMID: 12067837 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.

    Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E.

    Diabetes. 2001 Aug;50(8):1807-12.PMID: 11473042 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.

    Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, Landau BR, Ferrannini E.

    Diabetes. 2000 Aug;49(8):1367-73.PMID: 10923639 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The role of plasma fatty acid composition in endogenous glucose production in patients with type 2 diabetes mellitus.

    Clore JN, Allred J, White D, Li J, Stillman J.

    Metabolism. 2002 Nov;51(11):1471-7.PMID: 12404200 [PubMed - indexed for MEDLINE]Related articles

    8.

    Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.

    Boden G, Chen X, Stein TP.

    Am J Physiol Endocrinol Metab. 2001 Jan;280(1):E23-30.PMID: 11120655 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA.

    Diabetes. 2005 Nov;54(11):3148-53.PMID: 16249438 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.

    Boden G, Chen X.

    Diabetes. 1999 Mar;48(3):577-83.PMID: 10078559 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects.

    Chen X, Iqbal N, Boden G.

    J Clin Invest. 1999 Feb;103(3):365-72.PMID: 9927497 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM.

    Perriello G, Pampanelli S, Del Sindaco P, Lalli C, Ciofetta M, Volpi E, Santeusanio F, Brunetti P, Bolli GB.

    Diabetes. 1997 Jun;46(6):1010-6.PMID: 9166673 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effect of pioglitazone on the liver: role of adiponectin.

    Gastaldelli A, Miyazaki Y, Mahankali A, Berria R, Pettiti M, Buzzigoli E, Ferrannini E, DeFronzo RA.

    Diabetes Care. 2006 Oct;29(10):2275-81.PMID: 17003306 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Lipid-dependent control of hepatic glycogen stores in healthy humans.

    Stingl H, Krssák M, Krebs M, Bischof MG, Nowotny P, Fürnsinn C, Shulman GI, Waldhäusl W, Roden M.

    Diabetologia. 2001 Jan;44(1):48-54.PMID: 11206411 [PubMed - indexed for MEDLINE]Related articles

    15.

    Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

    Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA.

    Gastroenterology. 2007 Aug;133(2):496-506. Epub 2007 May 1.PMID: 17681171 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.

    Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4312-9.PMID: 15356026 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

    Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

    Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Gluconeogenesis and glycogenolysis in health and diabetes.

    Boden G.

    J Investig Med. 2004 Sep;52(6):375-8. Review.PMID: 15612450 [PubMed - indexed for MEDLINE]Related articles

    19.

    Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake.

    Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA.

    Diabetes. 1998 Nov;47(11):1735-47.PMID: 9792543 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Exogenous insulin replacement in type 2 diabetes reverses excessive hepatic glucose release, but not excessive renal glucose release and impaired free fatty acid clearance.

    Woerle HJ, Popa E, Dostou J, Welle S, Gerich J, Meyer C.

    Metabolism. 2002 Nov;51(11):1494-500.PMID: 12404204 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity